南大光電(300346.SZ)變更“年產170噸MO源和高K三甲基鋁生產項目”尚未使用的超募資金1.7億元 永久補充流動資金
格隆匯12月13日丨南大光電(300346.SZ)公佈,公司於2019年12月13日召開了第七屆董事會第二十二次會議,審議通過了《關於變更部分超募資金用途並永久補充流動資金的議案》,同意公司擬在保證超募資金投資項目的資金需求及超募資金使用計劃正常進行的前提下,變更“年產170噸MO源和高K三甲基鋁生產項目”尚未使用的超募資金共計人民幣1.7億元,用於永久補充流動資金。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.